动脉瘤性蛛网膜下腔出血临床表现与治疗的全球差异:综述与分析
该系统综述与Meta分析检索PubMed和Embase至2022年11月,纳入33篇文献共10,553例患者,比较高收入国家与低收入国家动脉瘤性蛛网膜下腔出血在人群特征、治疗方式和结局上的差异,发现两国高级别出血比例相近,但低收入国家未报告血管内弹簧圈栓塞治疗。
要点
- 高收入国家与低收入国家Fisher 3或4级动脉瘤性蛛网膜下腔出血的汇总加权患病率分别为79.8%(P<0.01)和84.1%(P<0.01)。
- 高收入国家与低收入国家男性动脉瘤性蛛网膜下腔出血患者的汇总加权患病率分别为35.8%(P<0.01)和45.0%(P<0.01)。
- 低收入国家仅报告手术夹闭治疗,汇总加权患病率为92.4%(P<0.01),高收入国家为65.6%(P<0.01),且低收入国家未报告弹簧圈栓塞治疗。
核心结论
- 高收入国家与低收入国家高级别蛛网膜下腔出血的汇总加权患病率相近,但低收入国家缺乏血管内弹簧圈栓塞治疗的报告。
- 需要进一步研究和讨论以明确治疗差异的原因及可干预的社会因素,从而改善全球动脉瘤性蛛网膜下腔出血的结局。
研究设计与样本
- 系统综述与Meta分析,检索PubMed和Embase数据库从最早记录至2022年11月的动脉瘤性蛛网膜下腔出血文献。
- 最终纳入33篇文章,代表10,553例患者,计算汇总加权患病率并报告随机效应模型率。
主要发现
- 高收入国家与低收入国家Fisher 3或4级动脉瘤性蛛网膜下腔出血的汇总加权患病率分别为79.8%(P<0.01)和84.1%(P<0.01)。
- 高收入国家与低收入国家男性动脉瘤性蛛网膜下腔出血患者的汇总加权患病率分别为35.8%(P<0.01)和45.0%(P<0.01)。
- 高收入国家与低收入国家动脉瘤性蛛网膜下腔出血患者接受治疗的汇总加权患病率分别为99.5%(P<0.01)和99.4%(P=0.16)。
- 高收入国家中35%(P<0.01)的动脉瘤性蛛网膜下腔出血患者动脉瘤接受弹簧圈栓塞治疗;低收入国家未报告弹簧圈栓塞治疗。
- 低收入国家仅报告手术夹闭治疗,汇总加权患病率为92.4%(P<0.01),高收入国家为65.6%(P<0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Aneurysmal subarachnoid hemorrhage (aSAH) is associated with high mortality rates. There is a significant gap in the literature describing global disparities in demographics, management, and outcomes among patients with aSAH. We aimed to conduct a systematic review and meta-analysis to assess global disparities in aSAH presentation and management. METHODS: PubMed and Embase databases were queried from earliest records to November 2022 for aSAH literature. Presentation, demographics, comorbidities, treatment methods, and outcomes data were collected. Articles that did not report aSAH-specific patient management and outcomes were excluded. Pooled weighted prevalence rates were calculated. Random effects model rates were reported. RESULTS: After screening, 33 articles representing 10,553 patients were included. The prevalence of Fisher grade 3 or 4 aSAH in high- and lower-income countries (HIC and LIC), respectively, was 79.8% (P < 0.01) and 84.1 (P < 0.01). Prevalence of male aSAH patients in HIC and LIC, respectively, was 35.8% (P < 0.01) and 45.0% (P < 0.01). Prevalence of treatment in aSAH patients was 99.5% (P < 0.01) and 99.4% (P = 0.16) in HIC and LIC, respectively. In HIC, 35% (P < 0.01) of aneurysms in aSAH patients were treated with coiling. No LIC reported coiling for aSAH treatment; LIC only reported rates of surgical clipping, with a total prevalence of 92.4% (P < 0.01) versus 65.6% (P < 0.01) in HIC. CONCLUSION: In this analysis, we found similar rates of high-grade SAH hemorrhages in HIC and LIC but a lack of endovascular coil embolization treatments reported in LIC. Additional research and discussion are needed to identify reasons for treatment disparities and intervenable societal factors to improve aSAH outcomes worldwide.
引用
- Lim J, Aguirre AO, Baig AA, et al. Global Disparities in the Presentation and Management of Aneurysmal Subarachnoid Hemorrhage: A Review and Analysis. World Neurosurg. 2024. PMID: 38750883. doi:10.1016/j.wneu.2024.05.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。